These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6120822)

  • 1. Disopyramide binding to serum protein in man and animals.
    Lima JJ; Haughey DB
    Drug Metab Dispos; 1981; 9(6):582-3. PubMed ID: 6120822
    [No Abstract]   [Full Text] [Related]  

  • 2. Species-dependent binding of disopyramide enantiomers.
    Lima JJ
    Drug Metab Dispos; 1988; 16(4):563-7. PubMed ID: 2903024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disopyramide concentrations in saliva.
    Aitio ML; Virtanen R; Lammintausta R
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):68-72. PubMed ID: 7061181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro plasma protein binding of propafenone and protein profile in eight mammalian species.
    Puigdemont A; Arboix M; Gaspari F; Bortolotti A; Bonati M
    Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):435-40. PubMed ID: 2781140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone (GH)-binding proteins in GH-resistant guinea pigs.
    Hull KL; Janssens WC; Baumbach WR; Harvey S
    Growth Regul; 1996 Sep; 6(3):165-75. PubMed ID: 8894650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of disopyramide.
    Karim A; Nissen C; Azarnoff DL
    J Pharmacokinet Biopharm; 1982 Oct; 10(5):465-94. PubMed ID: 6762414
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of protein binding on disopyramide clearance.
    Bryson SM; Lawrence JR; Steele WH; Campbell BC; Elliott HL; Sumner DJ
    Eur J Clin Pharmacol; 1982; 23(5):453-6. PubMed ID: 7151851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of altered disopyramide binding on its pharmacologic response in rabbits.
    Huang JD; Oie S
    J Pharmacol Exp Ther; 1982 Nov; 223(2):469-71. PubMed ID: 7131300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of tryptophan to plasma proteins in several species.
    Fuller RW; Roush BW
    Comp Biochem Physiol B; 1973 Oct; 46(2):273-6. PubMed ID: 4202192
    [No Abstract]   [Full Text] [Related]  

  • 10. Enantioselective plasma protein binding of bimoclomol.
    Visy J; Fitos I; Mády G; Urge L; Krajcsi P; Simonyi M
    Chirality; 2002 Aug; 14(8):638-42. PubMed ID: 12125033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of concentration-dependent protein binding on serum concentrations and urinary excretion of disopyramide and its metabolite following oral administration.
    Haughey DB; Lima JJ
    Biopharm Drug Dispos; 1983; 4(2):103-12. PubMed ID: 6882879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration-dependence of disopyramide binding to plasma protein and its influence on kinetics and dynamics.
    Lima JJ; Boudoulas H; Blanford M
    J Pharmacol Exp Ther; 1981 Dec; 219(3):741-7. PubMed ID: 7299695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate binding in animal plasma.
    Mantzos JD; Alevizou-Terzaki V; Gyftaki E
    Acta Haematol; 1974; 51(4):204-10. PubMed ID: 4211180
    [No Abstract]   [Full Text] [Related]  

  • 14. Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog.
    Cook CS; Karim A; Sollman P
    Drug Metab Dispos; 1982; 10(2):116-21. PubMed ID: 6124395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma protein binding of levamisole in several species.
    Sahagún A; Fernández N; Terán MT; García JJ; Sierra M; Diez MJ
    Methods Find Exp Clin Pharmacol; 1997 Apr; 19(3):185-7. PubMed ID: 9203167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding interaction between enantiomers of disopyramide and mono-N-dealkyldisopyramide on plasma protein.
    Takahashi H; Ogata H; Seki Y
    Drug Metab Dispos; 1991; 19(2):554-7. PubMed ID: 1676669
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of saturable binding to plasma proteins on the pharmacokinetic properties of disopyramide.
    Giacomini KM; Swezey SE; Turner-Tamiyasu K; Blaschke TF
    J Pharmacokinet Biopharm; 1982 Feb; 10(1):1-14. PubMed ID: 7069575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics and protein binding of disopyramide in pigs.
    Pedersen LE; Hermansen K; Olesen HP; Rasmussen SN
    Acta Pharmacol Toxicol (Copenh); 1986 Apr; 58(4):282-8. PubMed ID: 3716823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma protein binding of an N-pyrrolyl derivative penicillin in several mammalian species.
    Teran MT; Sierra M; Garcia JJ; Diez MJ; Arin MJ; Diez MT
    Res Vet Sci; 1988 Jul; 45(1):132-3. PubMed ID: 3222547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic study of disopyramide in normal man].
    Mallein R; Rondelet J; Boucherat M; Ksavrelof M; Pignat M
    Therapie; 1978; 33(4):463-73. PubMed ID: 734626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.